Nodthera Limited

ActiveSC540381 Private limited company

Incorporated: 15 July 2016 (10 years)
Industry: Research and experimental development on biotechnology (72110)
Directors: Christopher Damien Thomas Guiffre
Geoffrey Mcdonough
Alan Watt
Accounts type: Small
Region: Scotland
Address: 13 Queens Road
Aberdeen
AB15 4YL

Filing status

Accounts due: 31 December 2026
Last accounts: 31 December 2024
Conf. stmt due: 19 July 2027
Last conf. stmt: 5 July 2026

Charges

Total: 4
Outstanding: 2
Part satisfied: 0
Satisfied: 2

Officers 3 active

Officer details are public data from the Companies House register.

Guiffre, Christopher Damien Thomas

Director · Appointed 13 July 2026

American

Born August 1968 (58)

Mcdonough, Geoffrey

Director · Appointed 13 July 2026

American

Born August 1970 (56)

Watt, Alan

Director · Appointed 23 November 2022

British

Born September 1963 (63)

Officer history (14 former)

13 July 2026

Appointed Guiffre, Christopher Damien Thomas as Director

13 July 2026

Appointed Mcdonough, Geoffrey as Director

17 October 2025

Resigned Swisher, Jr., Daniel as Director

25 July 2024

Appointed Swisher, Jr., Daniel as Director

23 November 2022

Appointed Watt, Alan as Director

23 November 2022

Resigned Keeney, Adam James, Dr as Director

2 August 2022

Resigned Raidy, Kevin as Director

2 August 2022

Resigned Moldt, Peter as Director

2 August 2022

Resigned Roper, Elizabeth Ann, Dr as Director

2 August 2022

Resigned Pasteur, Alexander Thomas as Director

2 August 2022

Resigned Rocklage, Scott M as Director

2 August 2022

Resigned Lee, Kevin as Director

2 August 2022

Resigned Richter, Henrijette Elsebeth, Dr as Director

2 August 2022

Resigned Nicholson, Donald, Dr as Director

2 June 2021

Resigned Lüneborg, Nanna, Dr as Director

2 June 2021

Appointed Moldt, Peter as Director

26 May 2020

Appointed Lüneborg, Nanna, Dr as Director

26 May 2020

Appointed Pasteur, Alexander Thomas as Director

26 May 2020

Appointed Raidy, Kevin as Director

3 April 2019

Appointed Nicholson, Donald, Dr as Director

4 October 2018

Resigned Watt, Alan Paul, Dr as Director

4 October 2018

Appointed Lee, Kevin as Director

4 October 2018

Appointed Keeney, Adam James, Dr as Director

30 March 2018

Resigned Brzozka, Krzysztof Daniel as Director

30 March 2018

Appointed Rocklage, Scott M as Director

30 March 2018

Resigned Sirinakis, Kyparissia Katie as Director

30 March 2018

Appointed Richter, Henrijette Elsebeth, Dr as Director

1 September 2016

Appointed Watt, Alan Paul, Dr as Director

28 July 2016

Appointed Brzozka, Krzysztof Daniel as Director

28 July 2016

Appointed Sirinakis, Kyparissia Katie as Director

15 July 2016

Appointed Roper, Elizabeth Ann, Dr as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.

Former controllers (2)

6 September 2019

Ceased Epidarex Capital Management LLP — Owns 25–50% of shares

12 June 2017

Ceased Epidarex Capital Management LLP — Owns 75–100% of shares (as a firm)

Financials

Figures from 2021 accounts. Newer accounts, made up to 31 December 2024, are filed but not read yet. See them on Companies House

Net Assets: £22,841,718; down £1,918,503 (8%)
Cash: £19,841,414; down £558,877 (3%)
Turnover: £0; no change
Profit Before Tax: (£23,590,761); down £8,468,407 (56%)
Employees: 13; up 3 (30%)

Debt Ratio: 10%
Current Ratio: 9.8x
Return on Equity: -86%

Balance sheet detail

	2021
Fixed Assets	£13,917
Current Assets	£25,431,567
Debtors	£5,590,153
Cash	£19,841,414
Creditors (< 1 year)	£2,603,766
Creditors (> 1 year)	£0
Net Current Assets	£22,827,801
Net Assets	£22,841,718
Shareholder Funds	£22,841,718

Turnover	£0
Cost of Sales	£0
Gross Profit	£0
Admin Expenses	£4,600,840
Operating Profit	(£23,590,761)
Profit Before Tax	(£23,590,761)
Tax	£3,999,832
Profit for Period	(£19,590,929)